Provided by Tiger Trade Technology Pte. Ltd.

DiaMedica Therapeutics Inc.

8.14
+0.60007.96%
Post-market: 8.140.00000.00%16:10 EST
Volume:164.65K
Turnover:1.33M
Market Cap:436.13M
PE:-11.37
High:8.24
Open:7.74
Low:7.58
Close:7.54
52wk High:10.42
52wk Low:3.19
Shares:53.58M
Float Shares:32.94M
Volume Ratio:0.90
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7162
EPS(LYR):-0.6050
ROE:-64.12%
ROA:-38.33%
PB:8.45
PE(LYR):-13.46

Loading ...

DiaMedica Therapeutics Grants Stock Options to New Employee Under Inducement Plan

Reuters
·
Jan 17

BRIEF-Diamedica Therapeutics Provides Dm199 Preeclampsia Program Update

Reuters
·
Dec 18, 2025

DiaMedica Therapeutics Advances DM199 Preeclampsia Clinical Program Following FDA Meeting

Reuters
·
Dec 18, 2025

DiaMedica Therapeutics Inc - FDA Requests Additional Non-Clinical Study for Dm199

THOMSON REUTERS
·
Dec 18, 2025

DiaMedica Therapeutics Provides Dm199 Preeclampsia Program Update Following Pre-Ind Meeting With FDA

THOMSON REUTERS
·
Dec 18, 2025

10% Owner Jan Stahlberg Reports Acquisition of Common Shares of DiaMedica Therapeutics Inc

Reuters
·
Dec 09, 2025

Lake Street Sticks to Its Buy Rating for Diamedica Therapeutics (DMAC)

TIPRANKS
·
Nov 14, 2025

Diamedica Therapeutics (DMAC) Initiated with a Buy at Cantor Fitzgerald

TIPRANKS
·
Nov 14, 2025

DiaMedica Therapeutics Q3 Cash & Investments USD 55.3 Million

THOMSON REUTERS
·
Nov 13, 2025

DiaMedica Therapeutics Q3 Net Income USD -8.62 Million

THOMSON REUTERS
·
Nov 13, 2025

DiaMedica Therapeutics Inc - Has $55 Mln Cash With Runway Into 2H 2027

THOMSON REUTERS
·
Nov 13, 2025

Analysts Are Bullish on These Healthcare Stocks: Beyond Air (XAIR), Diamedica Therapeutics (DMAC)

TIPRANKS
·
Nov 12, 2025

DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference in London

Reuters
·
Nov 10, 2025

Press Release: DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025

Dow Jones
·
Nov 07, 2025

DiaMedica Therapeutics Files Initial Statement of Beneficial Ownership for Chief Marketing Officer Julie Krop

Reuters
·
Nov 04, 2025

TD Cowen Initiates DiaMedica Therapeutics at Buy

MT Newswires Live
·
Oct 30, 2025

BRIEF-DiaMedica Announces Inducement Grants Under Nasdaq Listing

Reuters
·
Sep 30, 2025

DiaMedica Therapeutics Grants Stock Options to New Employees Under Amended 2021 Inducement Incentive Plan

Reuters
·
Sep 30, 2025

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Sep 30, 2025

DiaMedica Therapeutics Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Sep 05, 2025